OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Microbiology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial overview: Fungal diversity: Now for something completely different	225
Renal implications of coronavirus disease 2019: insights into viral tropism and clinical outcomes	179
Convergence in domesticated fungi used for cheese and dry-cured meat maturation: beneficial traits, genomic mechanisms, and degeneration	137
Vertebrate and invertebrate animal infection models of Candida auris pathogenicity	130
PhoU: a multifaceted regulator in microbial signaling and homeostasis	116
The mycobiome: interactions with host and implications in diseases	112
Interplay between bacterial outer membranes and S-layers	109
Corrigendum to “Assembly and maturation of methyl-coenzyme M reductase in methanogenic archaea” [Curr Opin Microbiol, 87 (2025) 102637]	109
Harnessing ‘phage training’ to bolster the therapeutic potential of bacteriophages	109
Innate immune responses to Rickettsia: emerging themes and contrasts between species	107
The mass spectrometry of microbiome-mediated metabolism of food: challenges and opportunities	102
Starvation as a weapon in fungal–plant warfare	100
Synthetic microbial communities for studying and engineering the tree microbiome: challenges and opportunities	98
Transient microbial architects: tracing the legacy effects of ephemeral taxa during plant microbiome assembly	97
Innovative approaches in the discovery of terpenoid natural products	97
Editorial Board	91
Co-opting bacterial viruses for DNA exchange: structure and regulation of gene transfer agents	83
Function of autophagy genes in innate immune defense against mucosal pathogens	79
Editorial overview: Unraveling microbiome complexity	79
The impact of the host microbiota on Candida albicans infection	73
Insights into Alphaproteobacterial regulators of cell envelope remodeling	73
Fungus–insect interactions beyond bilateral regimes: the importance and strategy to outcompete host ectomicrobiomes by fungal parasites	71
Coevolution of a generalist pathogen with many hosts: the case of the amphibian chytrid Batrachochytrium dendrobatidis	69
Crosstalk between (p)ppGpp and other nucleotide second messengers	68
Manipulation of host cell plasma membranes by intracellular bacterial pathogens	68

Fungal effectors: past, present, and future	63
Control of bacterial second messenger signaling and motility by heme-based direct oxygen-sensing proteins	62
Ca2+-calmodulin signalling at the host-pathogen interface	60
Pathways of mRNA decay in trypanosomes	60
Phagosome maturation during fungal infection	56
Editorial overview: Human fungal pathogens: An increasing threat	53
Soterobionts: disease-preventing microorganisms and proposed strategies to facilitate their discovery	53
Advances in regulation of homeostasis through chromatin modifications by airway commensals	52
Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis	51
tRNAs as toxin targets in phage defence and a focus of counter-defence against abortive infection	51
Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection	50
Innovative and potential treatments for fungal central nervous system infections	49
Connecting microbial community assembly and function	48
Antifungal drug-resistance mechanisms in Candida biofilms	48
From coarse-grained metabolic rules to fine-grained control of microbial communities	47
Defining the expanding mechanisms of phage-mediated activation of bacterial immunity	47
Trace gas oxidation as a novel microbial dispersal trait	47
Circadian interactions between plants and microorganisms	45
Decoding the epigenetic blueprint behind Toxoplasma (pre)sexual commitment and chronic persistence	45
Host control by SPβ phage regulatory switch as potential manipulation strategy	44
Genetically engineered bacteriophages — their roles in combating intracellular bacterial infections and unraveling phage–eukaryote interactions	44